Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2020 Results Earnings Conference Call November 5, 2020 8:00 AM ET
Company Participants
Lina Li - Associate Director, IR
John Leonard - President and Chief Executive Officer
Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer
Glenn Goddard - Executive Vice President, Chief Financial Officer
David Lebwohl - Executive Vice President and Chief Medical Officer
Conference Call Participants
Salveen Richter - Goldman Sachs
Maury Raycroft - Jefferies
Madhu Kumar - Robert W. Baird & Co.
Gena Wang - Barclays
Joon Lee - Truist
Steven Seedhouse - Raymond James
Yanan Zhu - Wells Fargo
Operator
Good morning. My name is Drew, and I will be your conference operator today and welcome to the Intellia Therapeutics Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks we will open the call up for your questions. Please be advised that this call is being recorded at the company's request. [Operator Instructions]
At this time, I would like to turn it over To Lina Li, Associate Director of Investor Relations at Intellia. Please proceed.
Lina Li
Thank you, operator. Good morning, everyone, and welcome to Intellia's Third Quarter 2020 Earnings Call. Earlier today, we issued a press release outlining our progress this quarter and the topics we plan to discuss on today's call. This release can be found on the Investors and Media section of our website at intelliatx.com. This call is being broadcast live and a replay will also be archived on our website.
Before we get started, I would like to remind you that during this call, we may make certain forward-looking statements and ask that you refer to our SEC filings available at sec.gov for a discussion of potential risks and uncertainties. All information presented on this call
- Read more current NTLA analysis and news
- View all earnings call transcripts